Reduction of extramedullary erythropoiesis and amelioration of anemia in a β-thalassemia patient treated with thalidomide

Valeria Maria Pinto; Nicola Romano; Manuela Balocco; Paola Carrara; Martina Lamagna; Sabrina Quintino; Antonio Castaldi; Gian Luca Forni

doi:10.1002/ajh.27189

Reduction of extramedullary erythropoiesis and amelioration of anemia in a β-thalassemia patient treated with thalidomide

Am J Hematol. 2024 Mar;99(3):463-464. doi: 10.1002/ajh.27189. Epub 2023 Dec 26.

Authors

Valeria Maria Pinto¹, Nicola Romano², Manuela Balocco¹, Paola Carrara¹, Martina Lamagna¹, Sabrina Quintino¹, Antonio Castaldi², Gian Luca Forni¹

Affiliations

¹ Centro della Microcitemia, delle Anemie Congenite e dei Disordini del Metabolismo del Ferro, Ente Ospedaliero Ospedali Galliera, Genoa, Italy.
² Department of Diagnostic and Interventional Neuroradiology, Ente Ospedaliero Ospedali Galliera, Genoa, Italy.

PMID: 38146593
DOI: 10.1002/ajh.27189

Abstract

β-thalassemia patient treated with thalidomide: dimensional reduction of EMH foci (MRI evaluation) and reduction of hematological responce at follow-up.

Publication types

Case Reports

MeSH terms

Erythropoiesis
Hematologic Diseases*
Hematopoiesis, Extramedullary*
Humans
Thalidomide / therapeutic use
alpha-Thalassemia*
beta-Thalassemia* / complications
beta-Thalassemia* / drug therapy

Substances

Thalidomide